COL4A3
Collagen alpha-3(IV) chain
Also known as: CO4A3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01955
- Gene
- COL4A3
- Ensembl
- ENSG00000169031
- Chromosome
- 2
- Canonical length
- 1670 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Endoplasmic reticulum,Vesicles
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
1670 residues, UniProt reviewed canonical sequence.
>Q01955|COL4A3
1 MSARTAPRPQ VLLLPLLLVL LAAAPAASKG CVCKDKGQCF CDGAKGEKGE KGFPGPPGSP
61 GQKGFTGPEG LPGPQGPKGF PGLPGLTGSK GVRGISGLPG FSGSPGLPGT PGNTGPYGLV
121 GVPGCSGSKG EQGFPGLPGT LGYPGIPGAA GLKGQKGAPA KEEDIELDAK GDPGLPGAPG
181 PQGLPGPPGF PGPVGPPGPP GFFGFPGAMG PRGPKGHMGE RVIGHKGERG VKGLTGPPGP
241 PGTVIVTLTG PDNRTDLKGE KGDKGAMGEP GPPGPSGLPG ESYGSEKGAP GDPGLQGKPG
301 KDGVPGFPGS EGVKGNRGFP GLMGEDGIKG QKGDIGPPGF RGPTEYYDTY QEKGDEGTPG
361 PPGPRGARGP QGPSGPPGVP GSPGSSRPGL RGAPGWPGLK GSKGERGRPG KDAMGTPGSP
421 GCAGSPGLPG SPGPPGPPGD IVFRKGPPGD HGLPGYLGSP GIPGVDGPKG EPGLLCTQCP
481 YIPGPPGLPG LPGLHGVKGI PGRQGAAGLK GSPGSPGNTG LPGFPGFPGA QGDPGLKGEK
541 GETLQPEGQV GVPGDPGLRG QPGRKGLDGI PGTPGVKGLP GPKGELALSG EKGDQGPPGD
601 PGSPGSPGPA GPAGPPGYGP QGEPGLQGTQ GVPGAPGPPG EAGPRGELSV STPVPGPPGP
661 PGPPGHPGPQ GPPGIPGSLG KCGDPGLPGP DGEPGIPGIG FPGPPGPKGD QGFPGTKGSL
721 GCPGKMGEPG LPGKPGLPGA KGEPAVAMPG GPGTPGFPGE RGNSGEHGEI GLPGLPGLPG
781 TPGNEGLDGP RGDPGQPGPP GEQGPPGRCI EGPRGAQGLP GLNGLKGQQG RRGKTGPKGD
841 PGIPGLDRSG FPGETGSPGI PGHQGEMGPL GQRGYPGNPG ILGPPGEDGV IGMMGFPGAI
901 GPPGPPGNPG TPGQRGSPGI PGVKGQRGTP GAKGEQGDKG NPGPSEISHV IGDKGEPGLK
961 GFAGNPGEKG NRGVPGMPGL KGLKGLPGPA GPPGPRGDLG STGNPGEPGL RGIPGSMGNM
1021 GMPGSKGKRG TLGFPGRAGR PGLPGIHGLQ GDKGEPGYSE GTRPGPPGPT GDPGLPGDMG
1081 KKGEMGQPGP PGHLGPAGPE GAPGSPGSPG LPGKPGPHGD LGFKGIKGLL GPPGIRGPPG
1141 LPGFPGSPGP MGIRGDQGRD GIPGPAGEKG ETGLLRAPPG PRGNPGAQGA KGDRGAPGFP
1201 GLPGRKGAMG DAGPRGPTGI EGFPGPPGLP GAIIPGQTGN RGPPGSRGSP GAPGPPGPPG
1261 SHVIGIKGDK GSMGHPGPKG PPGTAGDMGP PGRLGAPGTP GLPGPRGDPG FQGFPGVKGE
1321 KGNPGFLGSI GPPGPIGPKG PPGVRGDPGT LKIISLPGSP GPPGTPGEPG MQGEPGPPGP
1381 PGNLGPCGPR GKPGKDGKPG TPGPAGEKGN KGSKGEPGPA GSDGLPGLKG KRGDSGSPAT
1441 WTTRGFVFTR HSQTTAIPSC PEGTVPLYSG FSFLFVQGNQ RAHGQDLGTL GSCLQRFTTM
1501 PFLFCNVNDV CNFASRNDYS YWLSTPALMP MNMAPITGRA LEPYISRCTV CEGPAIAIAV
1561 HSQTTDIPPC PHGWISLWKG FSFIMFTSAG SEGTGQALAS PGSCLEEFRA SPFLECHGRG
1621 TCNYYSNSYS FWLASLNPER MFRKPIPSTV KAGELEKIIS RCQVCMKKRHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COL4A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- retina: 34 nTPM
- skeletal muscle: 14 nTPM
- kidney: 14 nTPM
- thyroid gland: 13 nTPM
- lung: 12 nTPM
- tongue: 11 nTPM
Single-cell type
- podocytes: 2,820 nCPM
- cone photoreceptor cells: 1,074 nCPM
- müller glia: 949 nCPM
- distal convoluted tubule cells: 850 nCPM
- thyrotrophs: 842 nCPM
- loop of henle epithelial cells: 596 nCPM
Immune cell
- memory B-cell: 1 nTPM
- naive B-cell: 0.3 nTPM
- MAIT T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- choroid plexus: 46 nTPM
- thalamus: 15 nTPM
- medulla oblongata: 8.8 nTPM
- midbrain: 8.4 nTPM
- pons: 7.4 nTPM
- white matter: 6.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COL4A3.
Disease | AllUniProt
Conditions COL4A3 is implicated in, by any mechanism.
- Hematuria, benign familial, 2 (BFH2) MIM:620320
- Alport syndrome 3A, autosomal dominant (ATS3A) MIM:104200
- Alport syndrome 3B, autosomal recessive (ATS3B) MIM:620536
Disease | GeneticClinVar
886 pathogenic / likely-pathogenic of 3,465 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal dominant Alport syndrome
- Alport syndrome
- Alport syndrome 3b, autosomal recessive
- Autosomal recessive Alport syndrome
- Hematuria, benign familial, 2
Disease | ImmuneIEDB
Conditions an epitope on COL4A3 was assayed in.
- Goodpasture syndrome B and T cell
- autoimmune vasculitis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.99
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- cell surface receptor signaling pathway
- collagen fibril organization
- collagen-activated tyrosine kinase receptor signaling pathway
- endothelial cell apoptotic process
- glomerular basement membrane development
- negative regulation of angiogenesis
- negative regulation of cell population proliferation
- negative regulation of vascular endothelial cell proliferation
- sensory perception of sound
Molecular functions
- extracellular matrix structural constituent conferring tensile strength
- integrin binding
- metalloendopeptidase inhibitor activity
- structural molecule activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of COL4A3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COL4A3 as an antibody target. Whether an autoantibody or antibody against COL4A3 could matter depends on whether native COL4A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COL4A3 is annotated as secreted, so native COL4A3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli.
- The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein.
Loading the interactive Seroatlas protein explorer...